Atlas Trials

Evaluation of Heart Function in Breast Cancer Patients Using Trastuzumab

Clinical trial NCT04961307 · UNKNOWN

Trial details

NCT number
NCT04961307
Sponsor
Peking University Third Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
CardiotoxicityAntitumor DrugsBreast CancerTrastuzumab
Start date
2019-07-05
Primary completion
2021-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.